Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a ...

Moderna MRNA shares are moving higher on Monday after the company won FDA Fast Track status for an oncology program, helping ...

Moderna (NasdaqGS:MRNA) plans to present Phase 1/2 data for its mRNA-4359 cancer antigen therapy combined with pembrolizumab ...

CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will ...

Valued at a market cap of $21.2 billion, Moderna, Inc. (MRNA) is a biotechnology company that pioneered the use of messenger ...

The U.S. FDA has granted Fast Track designation for mRNA-4359 in combination with pembrolizumab for the treatment of ...

Moderna, Inc. recently participated in the 5th LNP Formulation & Process Development Summit in Boston and scheduled a May 1, ...

The US drugmaker said it was informed by the Data Safety Monitoring Board that its vaccine had met statistical criteria ...

Production of Moderna COVID-19 vaccines at a plant in Spain can continue, the European Union drugs regulator said on Friday, ...

That raises the stakes for a second area of Moderna’s research. In a partnership with Merck, it’s been using its mRNA ...

Morgan Stanley said on Tuesday that Moderna may provide the vast majority of COVID-19 vaccine doses to the US.

Biotech giant Moderna announced it will lay off 10% of its workforce in a move CEO Stéphane Bancel called “a difficult decision but necessary step forward,” in an internal memo sent to employees on ...